Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: TheGO-CLLEARStudy by the CzechCLLStudy Group

HEMATOLOGICAL ONCOLOGY

Panovska, A; Nemcova, L; Nekvindova, L; Spacek, M; Simkovic, M; Papajik, T; Brejcha, M; Lysak, D; Zuchnicka, J; Novak, J; Starostka, D; Poul, H; Vrbacky, F; Vodarek, P; Urbanova, R; Plevova, K; Pospisilova, S; Maslejova, S; Brychtova, Y; Koritakova, E; Smolej, L; Doubek, M, 2020: Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: TheGO-CLLEARStudy by the CzechCLLStudy Group. HEMATOLOGICAL ONCOLOGY 38(4), p. 509 - 516, doi: 10.1002/hon.2744

Research Groups:

• Medical Genomics - Šárka Pospíšilová

CEITEC authors:

• Prof. Šárka Pospíšilová, Ph.D.
• Karla Plevová, Ph.D.
• Prof. Michael Doubek, Ph.D.